These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27491607)

  • 1. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD
    Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
    Henry TD; Losordo DW; Traverse JH; Schatz RA; Jolicoeur EM; Schaer GL; Clare R; Chiswell K; White CJ; Fortuin FD; Kereiakes DJ; Zeiher AM; Sherman W; Hunt AS; Povsic TJ
    Eur Heart J; 2018 Jun; 39(23):2208-2216. PubMed ID: 29315376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial, autologous CD34+ cell therapy for refractory angina.
    Losordo DW; Henry TD; Davidson C; Sup Lee J; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Traverse JH; Amrani D; Ewenstein BM; Riedel N; Story K; Barker K; Povsic TJ; Harrington RA; Schatz RA;
    Circ Res; 2011 Aug; 109(4):428-36. PubMed ID: 21737787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.
    Velagapudi P; Turagam M; Kolte D; Khera S; Hyder O; Gordon P; Aronow HD; Leopold J; Abbott JD
    Cardiovasc Revasc Med; 2019 Mar; 20(3):215-219. PubMed ID: 29908826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous CD34
    Henry TD; Schaer GL; Traverse JH; Povsic TJ; Davidson C; Lee JS; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Patel AN; Riedel N; Junge C; Hunt A; Kereiakes DJ; White C; Harrington RA; Schatz RA; Losordo DW;
    Cell Transplant; 2016; 25(9):1701-1711. PubMed ID: 27151378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
    Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
    Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial.
    Jimenez-Quevedo P; Gonzalez-Ferrer JJ; Sabate M; Garcia-Moll X; Delgado-Bolton R; Llorente L; Bernardo E; Ortega-Pozzi A; Hernandez-Antolin R; Alfonso F; Gonzalo N; Escaned J; Bañuelos C; Regueiro A; Marin P; Fernandez-Ortiz A; Neves BD; Del Trigo M; Fernandez C; Tejerina T; Redondo S; Garcia E; Macaya C
    Circ Res; 2014 Nov; 115(11):950-60. PubMed ID: 25231095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.
    Povsic TJ; Losordo DW; Story K; Junge CE; Schatz RA; Harrington RA; Henry TD
    Am Heart J; 2012 Nov; 164(5):689-697.e3. PubMed ID: 23137499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ autologous human stem cells in treating refractory angina.
    Perin EC; Willerson JT
    Circ Res; 2011 Aug; 109(4):351-2. PubMed ID: 21817161
    [No Abstract]   [Full Text] [Related]  

  • 12. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34
    Johnson GL; Henry TD; Povsic TJ; Losordo DW; Garberich RF; Stanberry LI; Strauss CE; Traverse JH
    Stem Cells Transl Med; 2020 Oct; 9(10):1147-1152. PubMed ID: 32531108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promise of autologous CD34+ stem/progenitor cell therapy for treatment of cardiovascular disease.
    Prasad M; Corban MT; Henry TD; Dietz AB; Lerman LO; Lerman A
    Cardiovasc Res; 2020 Jul; 116(8):1424-1433. PubMed ID: 32022845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries.
    Corban MT; Toya T; Albers D; Sebaali F; Lewis BR; Bois J; Gulati R; Prasad A; Best PJM; Bell MR; Rihal CS; Prasad M; Ahmad A; Lerman LO; Solseth ML; Winters JL; Dietz AB; Lerman A
    Circ Res; 2022 Feb; 130(3):326-338. PubMed ID: 34923853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
    Povsic TJ; Henry TD; Ohman EM; Pepine CJ; Crystal RG; Rosengart TK; Reinhardt RR; Dittrich HC; Traverse JH; Answini GA; Mokadam NA
    Am Heart J; 2021 Nov; 241():38-49. PubMed ID: 34224684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
    Losordo DW; Kibbe MR; Mendelsohn F; Marston W; Driver VR; Sharafuddin M; Teodorescu V; Wiechmann BN; Thompson C; Kraiss L; Carman T; Dohad S; Huang P; Junge CE; Story K; Weistroffer T; Thorne TM; Millay M; Runyon JP; Schainfeld R;
    Circ Cardiovasc Interv; 2012 Dec; 5(6):821-30. PubMed ID: 23192920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.
    Briguori C; Reimers B; Sarais C; Napodano M; Pascotto P; Azzarello G; Bregni M; Porcellini A; Vinante O; Zanco P; Peschle C; Condorelli G; Colombo A
    Am Heart J; 2006 Mar; 151(3):674-80. PubMed ID: 16504630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive meta-analysis of stem cell therapy for chronic angina.
    Shah R; Latham SB; Khan SA; Shahreyar M; Hwang I; Jovin IS
    Clin Cardiol; 2018 Apr; 41(4):525-531. PubMed ID: 29664162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.
    Mathiasen AB; Haack-Sørensen M; Jørgensen E; Kastrup J
    Int J Cardiol; 2013 Dec; 170(2):246-51. PubMed ID: 24211066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.